10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001628280-20-012247`
Period End Date	20200630
Filing Date	20200810
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	ameh-20200630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 103 Income Statement 80 Cash Flow Statement 115 Stockholders Equity 34

Balance Sheet 103 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$52.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$103.19M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$152.44M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$75.00K	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$117.66M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$116.54M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$11.00M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$17.59M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	36.31M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	35.91M	shares	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$59.33M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$48.14M	USD	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	17.46M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$15.92M	USD	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	17.48M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$16.89M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.31M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$11.19M	USD	Point-in-time
Loans receivable	`NotesAndLoansReceivableNetCurrent`	$6.42M	USD	Point-in-time
Loans receivable	`NotesAndLoansReceivableNetCurrent`	$6.42M	USD	Point-in-time
Loans receivable related parties	`NotesReceivableRelatedPartiesCurrent`	-	USD	Point-in-time
Loans receivable related parties	`NotesReceivableRelatedPartiesCurrent`	$16.50M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$329.07M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$380.55M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$746.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$746.00K	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$11.48M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$12.13M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$103.01M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$94.79M	USD	Point-in-time
Goodwill	`Goodwill`	$239.05M	USD	Point-in-time
Goodwill	`Goodwill`	$238.50M	USD	Point-in-time
Investment in other entities equity method	`EquityMethodInvestments`	$28.43M	USD	Point-in-time
Investment in other entities equity method	`EquityMethodInvestments`	$26.82M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$37.08M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$896.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.22M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$14.25M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$22.49M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.68M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$399.64M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$452.67M	USD	Point-in-time
Total assets	`Assets`	$833.22M	USD	Point-in-time
Total assets	`Assets`	$728.71M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$27.28M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$24.79M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$2.03M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$1.85M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$33.64M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$58.73M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$70.27M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$42.94M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$4.53M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$42.21M	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$271.00K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$431.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$102.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$102.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$3.35M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.99M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$9.50M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$9.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$105.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$152.51M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$18.27M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$13.65M	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$355.00K	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$416.00K	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$11.37M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$17.42M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$230.46M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$232.17M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$261.88M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$262.23M	USD	Point-in-time
Total liabilities	`Liabilities`	$367.65M	USD	Point-in-time
Total liabilities	`Liabilities`	$414.39M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$210.98M	USD	Point-in-time
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$168.72M	USD	Point-in-time
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 36,309,513 and 35,908,057 shares outstanding, excluding 17,475,707 and 17,458,810 treasury shares, at June 30, 2020, and December 31, 2019, respectively	`CommonStockValue`	$36.00K	USD	Point-in-time
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 36,309,513 and 35,908,057 shares outstanding, excluding 17,475,707 and 17,458,810 treasury shares, at June 30, 2020, and December 31, 2019, respectively	`CommonStockValue`	$36.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$163.99M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$159.61M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$43.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$31.91M	USD	Point-in-time
Retained earnings	`StockholdersEquity`	$191.55M	USD	Point-in-time
Retained earnings	`StockholdersEquity`	$207.02M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$786.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$825.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$186.09M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$207.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$197.96M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders equity	`LiabilitiesAndStockholdersEquity`	$728.71M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders equity	`LiabilitiesAndStockholdersEquity`	$833.22M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$130.05M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$330.27M	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$165.17M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$225.81M	USD	2 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$184.79M	USD	2 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$101.36M	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	$280.28M	USD	2 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$136.08M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$11.82M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$11.56M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$23.39M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$22.08M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts`	$8.87M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts`	$9.33M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts`	$4.63M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts`	$4.46M	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	2 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$-2.31M	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$-1.36M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$214.38M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$152.26M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$115.32M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$313.00M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$11.42M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$17.27M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$12.91M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$14.73M	USD	1 Quarter
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$834.00K	USD	1 Quarter
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-892.00K	USD	2 Qtrs
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.89M	USD	2 Qtrs
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-42.00K	USD	1 Quarter
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$99.65M	USD	1 Quarter
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	1 Quarter
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	2 Qtrs
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$99.65M	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.67M	USD	1 Quarter
Interest expense	`InterestExpense`	$5.54M	USD	2 Qtrs
Interest expense	`InterestExpense`	$311.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$522.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$863.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.79M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$474.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$797.00K	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$211.00K	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$24.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$1.28M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$1.38M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$100.17M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$145.00K	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$-406.00K	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$99.95M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$14.87M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$112.86M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$117.44M	USD	2 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$11.02M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$31.86M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$33.45M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$4.21M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$2.80M	USD	2 Qtrs
Net income	`ProfitLoss`	$81.00M	USD	1 Quarter
Net income	`ProfitLoss`	$8.21M	USD	2 Qtrs
Net income	`ProfitLoss`	$83.99M	USD	2 Qtrs
Net income	`ProfitLoss`	$10.66M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$72.89M	USD	2 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.12M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.53M	USD	2 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$73.96M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$3.54M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$11.10M	USD	2 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$3.69M	USD	2 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$7.04M	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.31	USD	2 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.10	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.11	USD	2 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.20	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.10	USD	2 Qtrs
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.30	USD	2 Qtrs
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.09	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.19	USD	1 Quarter

Cash Flow Statement 115 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$81.00M	USD	1 Quarter
Net income	`ProfitLoss`	$8.21M	USD	2 Qtrs
Net income	`ProfitLoss`	$83.99M	USD	2 Qtrs
Net income	`ProfitLoss`	$10.66M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$9.33M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$8.87M	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$658.00K	USD	2 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	2 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$-2.31M	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$-1.36M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$1.91M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$676.00K	USD	2 Qtrs
Unrealized loss (gain) from investment in equity securities	`UnrealizedGainLossOnInvestments`	$15.00K	USD	2 Qtrs
Unrealized loss (gain) from investment in equity securities	`UnrealizedGainLossOnInvestments`	$-25.00K	USD	2 Qtrs
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$834.00K	USD	1 Quarter
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-892.00K	USD	2 Qtrs
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.89M	USD	2 Qtrs
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-42.00K	USD	1 Quarter
Gain on sale of equity method investments	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$99.65M	USD	1 Quarter
Gain on sale of equity method investments	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	1 Quarter
Gain on sale of equity method investments	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	2 Qtrs
Gain on sale of equity method investments	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$99.65M	USD	2 Qtrs
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-4.47M	USD	2 Qtrs
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-549.00K	USD	2 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$-588.00K	USD	2 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$6.28M	USD	2 Qtrs
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$11.19M	USD	2 Qtrs
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$12.66M	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-966.00K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$11.90M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$2.74M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$873.00K	USD	2 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$1.10M	USD	2 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$1.68M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$243.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$5.09M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-3.04M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$3.34M	USD	2 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$260.00K	USD	2 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-174.00K	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-3.82M	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$11.25M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-11.62M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$37.68M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	$-1.25M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	$-1.04M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$12.57M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-22.02M	USD	2 Qtrs
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$41.52M	USD	2 Qtrs
Proceeds from repayment of loans receivable related parties	`ProceedsFromCollectionOfLoansReceivable`	$16.50M	USD	2 Qtrs
Proceeds from repayment of loans receivable related parties	`ProceedsFromCollectionOfLoansReceivable`	-	USD	2 Qtrs
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$6.42M	USD	2 Qtrs
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.14M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$8.00K	USD	2 Qtrs
Purchases of investment equity method	`PaymentsToAcquireEquityMethodInvestments`	$2.16M	USD	2 Qtrs
Purchases of investment equity method	`PaymentsToAcquireEquityMethodInvestments`	$500.00K	USD	2 Qtrs
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	$52.74M	USD	2 Qtrs
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$451.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$378.00K	USD	2 Qtrs
Dividend received	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	2 Qtrs
Dividend received	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$240.00K	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-50.25M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$67.15M	USD	2 Qtrs
Repayment of bank loan and lines of credit	`RepaymentsOfBankLoanAndLinesOfCredit`	$8.04M	USD	2 Qtrs
Repayment of bank loan and lines of credit	`RepaymentsOfBankLoanAndLinesOfCredit`	-	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$10.94M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$30.19M	USD	2 Qtrs
Repayment of term loan	`RepaymentsOfLongTermDebt`	$2.38M	USD	2 Qtrs
Repayment of term loan	`RepaymentsOfLongTermDebt`	-	USD	2 Qtrs
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$25.00K	USD	1 Quarter
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$61.00K	USD	2 Qtrs
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$35.00K	USD	1 Quarter
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$50.00K	USD	2 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$898.00K	USD	2 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$2.86M	USD	2 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$40.00K	USD	2 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$788.00K	USD	2 Qtrs
Borrowings on line of credit	`ProceedsFromLongTermLinesOfCredit`	$39.60M	USD	2 Qtrs
Borrowings on line of credit	`ProceedsFromLongTermLinesOfCredit`	-	USD	2 Qtrs
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	$205.00K	USD	2 Qtrs
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$21.63M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-30.55M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$49.18M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-50.63M	USD	2 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$153.19M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.00M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$153.19M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$16.70M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$439.00K	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$2.62M	USD	2 Qtrs
Deferred tax liability adjustment to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	-	USD	2 Qtrs
Deferred tax liability adjustment to goodwill	`DeferredTaxLiabilityAdjustedToGoodwill`	$8.36M	USD	2 Qtrs
Preferred shares received from sale of equity method investment	`NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1`	-	USD	2 Qtrs
Preferred shares received from sale of equity method investment	`NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1`	$36.18M	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$52.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$103.19M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$152.44M	USD	Point-in-time
Restricted cash non-current	`RestrictedCashEquivalentsNoncurrent`	$4.28M	USD	Point-in-time
Restricted cash non-current	`RestrictedCashEquivalentsNoncurrent`	$746.00K	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.00M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$153.19M	USD	Point-in-time

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$186.09M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$207.85M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$197.96M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$7.33M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$3.77M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$4.15M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$550.00K	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$301.00K	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	-	USD	1 Quarter
Purchase of noncontrolling interest	`MinorityInterestDecreaseFromRedemptions`	-	USD	1 Quarter
Purchase of noncontrolling interest	`MinorityInterestDecreaseFromRedemptions`	-	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$140.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$722.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$758.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$2.28M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$143.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$128.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$852.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.06M	USD	1 Quarter
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardCancelled`	$236.00K	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$347.00K	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$942.00K	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$186.09M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$207.85M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$197.96M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.